Allarity Therapeutics Reports Third Quarter 2026 Results and Provides Full Year 2026 Financial Guidance

Allarity Therapeutics, Inc. announced its financial results for the third quarter of 2026. Alongside the quarterly performance, the company provided updated financial guidance for the full year 2026. These disclosures offer investors insight into the company's current operational status and its expectations for the remainder of the fiscal year.